All Srivatsan Parthasarathy articles
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
